Literature DB >> 7550324

A gene for autosomal dominant sacral agenesis maps to the holoprosencephaly region at 7q36.

S A Lynch1, P M Bond, A J Copp, W O Kirwan, S Nour, R Balling, E Mariman, J Burn, T Strachan.   

Abstract

Sacral agenesis is a rare disorder of uncertain incidence that has been reported in diverse populations. Although usually sporadic and most commonly associated with maternal diabetes, there is a hereditary form which may occur in isolation or with a presacral mass (anterior meningocele and/or presacral teratoma) and anorectal abnormalities, which constitute the Currarino triad (MIM 176450). The radiological hallmark of hereditary sacral agenesis is a hemi-sacrum (sickle-shaped sacrum) with intact first sacral vertebra. Bowel obstruction is the usual neonatal presentation, but, unlike other neural tube defects, adult presentation is not uncommon. The major pathology is confined to the pelvic cavity and may present as a space-occupying lesion or meningitis due to ascending infection. All recurrences in families have been compatible with autosomal dominant inheritance except for those associated with the isomerism gene at Xq24-q27.1 (ref. 3). Several associated cytogenetic defects have been reported, including 7q deletions. Previous studies failed to detect linkage to HLA markers, but we now present evidence for a location on 7q36. The same region also contains a gene for holoprosencephaly, an early malformation of the extreme rostral end of the neural tube.

Entities:  

Mesh:

Year:  1995        PMID: 7550324     DOI: 10.1038/ng0995-93

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  36 in total

1.  Involvement of the HLXB9 homeobox gene in Currarino syndrome.

Authors:  E Belloni; G Martucciello; D Verderio; E Ponti; M Seri; V Jasonni; M Torre; M Ferrari; L C Tsui; S W Scherer
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Cebocephaly, alobar holoprosencephaly, spina bifida, and sirenomelia in a stillbirth.

Authors:  C P Chen; S L Shih; F F Liu; S W Jan
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

3.  Currarino triad with a terminal deletion 7q35-->qter.

Authors:  M Masuno; K Imaizumi; N Aida; Y Tanaka; K Sekido; Y Ohhama; T Nishi; Y Kuroki
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

4.  Leiomyomatosis peritonealis disseminata in association with Currarino syndrome?

Authors:  Carmine Nappi; Attilio Di Spiezio Sardo; Vincenzo Dario Mandato; Giuseppe Bifulco; Elisa Merello; Antonio Savanelli; Chiara Mignogna; Valeria Capra; Maurizio Guida
Journal:  BMC Cancer       Date:  2006-05-10       Impact factor: 4.430

5.  Isolated sacral agenesis in a fetus monosomic for 7q36.1-->qter.

Authors:  N M Savage; N A Maclachlan; C A Joyce; I E Moore; J A Crolla
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

Review 6.  Defects in the determination of left-right asymmetry.

Authors:  M P Splitt; J Burn; J Goodship
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

Review 7.  Anorectal malformation: the etiological factors.

Authors:  Chen Wang; Long Li; Wei Cheng
Journal:  Pediatr Surg Int       Date:  2015-04-22       Impact factor: 1.827

8.  Currarino Syndrome and HPE Microform Associated with a 2.7-Mb Deletion in 7q36.3 Excluding SHH Gene.

Authors:  C Coutton; B Poreau; F Devillard; C Durand; S Odent; C Rozel; G Vieville; F Amblard; P-S Jouk; V Satre
Journal:  Mol Syndromol       Date:  2013-10-02

9.  Caudal dysgenesis in Islet-1 transgenic mice.

Authors:  Yunhua Li Muller; Yir Gloria Yueh; Paul J Yaworsky; J Michael Salbaum; Claudia Kappen
Journal:  FASEB J       Date:  2003-05-08       Impact factor: 5.191

10.  Microcephaly, sensorineural deafness and Currarino triad with duplication-deletion of distal 7q.

Authors:  Piero Pavone; Martino Ruggieri; Ilaria Lombardo; Jyotsna Sudi; Roberta Biancheri; Danilo Castellano-Chiodo; Andrea Rossi; Gemma Incorpora; Norma J Nowak; Susan L Christian; Lorenzo Pavone; William B Dobyns
Journal:  Eur J Pediatr       Date:  2009-10-17       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.